A randomized phase III protocol for the evaluation of misonidazole with radiation in the treatment of patients with brain metastasis (RTOG-7916)
โ Scribed by Lydia Komarnicky; Theodore Phillips; Karen Martz; Mohammed Mohiuddin; Luther Brady; Steven Isaacson; Sucha Asbell; Raul Urtasun
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 236 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Metastatic melanoma is a disease associated with a poor prognosis, and dacarbazine is still the reference agent. The authors conducted a randomized trial to test the benefit of adding tamoxifen to dacarbazine and carboplatin chemotherapy for previously untreated patients with metast
I of a Somatostatin Analogue (Octreotide) in the Treatment of Patients with Asymptomatic Advanced Colon Cancer."' The disappointing results of this study contrast with recently reported cellular kinetic data for rectal cancer treatment with somatostatin. It should be noted that the dosage used in o
The current study presents mature results from a Phase III randomized trial comparing radiation therapy and concurrent chemoradiotherapy in patients with resectable American Joint Committee on Cancer Stage III and IV disease.